Atypical fractures associated with bisphosphonate use post-renal transplantation

Nephrology

Volumn 17, Issue SUPPL. 1, 2012, Pages 1-4

  Burke, Michael T ^a,b   Hollett, Peter R ^a   Gray, Nicholas A ^a,b  

^a NAMBOUR GENERAL HOSPITAL   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Atypical fracture; Bisphosphonate; Kidney; Transplant

Indexed keywords

ALENDRONIC ACID; BISPHOSPHONIC ACID DERIVATIVE; CALCITRIOL; CALCIUM CARBONATE; CYCLOSPORIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PAMIDRONIC ACID; PARATHYROID HORMONE; PARATHYROID HORMONE[1-34]; PREDNISONE;

ADULT; ARTICLE; ATYPICAL FRACTURE; BONE DENSITY; BONE DISEASE; BONE GRAFT; BONE MINERAL; BONE REMODELING; BONE TURNOVER; CALCIUM BLOOD LEVEL; CASE REPORT; CHRONIC KIDNEY DISEASE; COMPUTER ASSISTED TOMOGRAPHY; CONSERVATIVE TREATMENT; CORTICOSTEROID THERAPY; DIABETES MELLITUS; DISEASE COURSE; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG SUBSTITUTION; DRUG USE; DRUG WITHDRAWAL; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; FEMUR FRACTURE; FEMUR NECK; FEMUR SUBTROCHANTERIC FRACTURE; FRACTURE; FRACTURE TREATMENT; HEMODIALYSIS; HORMONE SUBSTITUTION; HUMAN; HYPERCALCEMIA; HYPERPHOSPHATEMIA; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LUMBAR SPINE; MORBIDITY; NUCLEAR MAGNETIC RESONANCE IMAGING; OPEN REDUCTION; ORGAN TRANSPLANTATION; OSTEOSYNTHESIS; PARATHYROID HORMONE BLOOD LEVEL; PARATHYROID HYPERPLASIA; PARATHYROIDECTOMY; PELVIS FRACTURE; PHOSPHATE BLOOD LEVEL; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; SECONDARY HYPERPARATHYROIDISM; STRESS FRACTURE; TREATMENT OUTCOME;

ABSORPTIOMETRY, PHOTON; BONE DENSITY; BONE DENSITY CONSERVATION AGENTS; DIPHOSPHONATES; FEMALE; FEMORAL NECK FRACTURES; FRACTURES, BONE; FRACTURES, STRESS; HUMANS; HYPERCALCEMIA; HYPERPARATHYROIDISM; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; LUMBAR VERTEBRAE; MIDDLE AGED; PARATHYROIDECTOMY; PREDICTIVE VALUE OF TESTS; SPINAL FRACTURES; TIME FACTORS; TREATMENT OUTCOME;

EID: 84859816404     PISSN: 13205358     EISSN: 14401797     Source Type: Journal    
DOI: 10.1111/j.1440-1797.2012.01579.x     Document Type: Article

References (5)

1. Schilcher J, Michaelsson K, Aspenberg P. Bisphosphonate use and atypical fractures of the femoral shaft. N. Engl. J. Med. 2011; 364: 1728-37.
2. Coco M, Glicklich D, Faugere MC, Burris L, Bognar I, Durkin P. Prevention of bone loss in renal transplant recipients: A prospective, randomised trial of intravenous pamidronate. J. Am. Soc. Nephrol. 2003; 14: 2669-76. (Pubitemid 37169355)
3. Akaberi S, Simonsen O, Lindergard B, Nyberg G. Can DXA predict fractures in renal transplant patients? Am. J. Transplant. 2008; 8: 2647-51.
4. Kidney Disease: Improving Global Outcomes (KDIGO) Transplant Work Group. Special Issue: KDIGO clinical practice guideline for the care of kidney transplant recipients. Am. J. Transplant. 2009; 9 (Suppl 3): S93-6.
5. Schmid T, Muller P, Spelsberg F. Parathyroidectomy after renal transplantation: A retrospective analysis of long term outcome. Nephrol. Dial. Transplant. 1997; 12: 2393-6. (Pubitemid 27474625)